Followers | 0 |
Posts | 1151 |
Boards Moderated | 0 |
Alias Born | 07/10/2003 |
![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, August 14, 2004 6:56:03 AM
*************************************************************************************************
Ancestry 3.0 would take about a year to develop, but will require between $750K to $1 million to fund the research. DNAP would like to solicit a partner willing to fund it's development in exchange for a share of downstream revenues.
- Ovanome is about a year from market, and DNAP anticipates marketing through a partner. I asked if Statnome was similarly a year out, and the response surprised me. Tony indicated that Statnome would be marketed sooner and the marketing would be handled by DNAP. Obviously, the company is anticipating a much larger market for the Statin classifers which would make it cost effective to run the samples on the UHT.
************************************************************************************************
I really have to share this because i think there's something odd about the fact that there is so little info. out on Statnome that i cant help wonder if Tony is going to pull a BIG Surprise on everyone with News on either Statnome coming out or Ovanome this year. Tony has said Statnome is really top secret and a very big money maker.And then in the EXECUTIVE SUMMARY OF OVANOME we have this -
***************************************************************************************************
The clinical trial for OVANOME will be finished in early 2004. An application for approval to market, if required, will be submitted to the FDA by mid-2004 and approval obtained by early 2005. DNAP has a patent pending for compositions and methods relating to OVANOME. Sales of the OVANOME products to labs in 2005 will result in income of $4 million. This product launch will create a new, emerging US market of over $16 million. OVANOME is forecast to reach a peak-year sales record of $12 million in year three and hold steady for several years as the classifier test of choice in this market niche.
*******************************************************************************************
I guess i would like to believe that Tony is going to pull a Big surprise on us all this year.To much to wish for i guess.Dont mine me i'm just dreaming.
God Bless
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM